Brooks Moore & Associates’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.31M | Buy |
47,455
+7,150
| +18% | +$653K | 1.93% | 15 |
|
|
2026
Q1 | $4.14M | Buy |
40,305
+993
| +3% | +$112K | 2.07% | 16 |
|
|
2025
Q4 | $4.93M | Buy |
39,312
+585
| +2% | +$74.5K | 2.42% | 11 |
|
|
2025
Q3 | $5.19M | Sell |
38,727
-332
| -0.8% | -$43.6K | 2.63% | 8 |
|
|
2025
Q2 | $4.93M | Sell |
39,059
-143
| -0.4% | -$18.9K | 2.66% | 8 |
|
|
2025
Q1 | $5.2M | Sell |
39,202
-505
| -1% | -$64.3K | 2.93% | 9 |
|
|
2024
Q4 | $4.49M | Sell |
39,707
-120
| -0.3% | -$13.9K | 2.66% | 13 |
|
|
2024
Q3 | $4.54M | Hold |
39,827
| – | – | 2.68% | 11 |
|
|
2024
Q2 | $4.14M | Buy |
39,827
+1,035
| +3% | +$110K | 2.66% | 12 |
|
|
2024
Q1 | $4.41M | Sell |
38,792
-613
| -2% | -$70.3K | 2.83% | 10 |
|
|
2023
Q4 | $4.34M | Sell |
39,405
-240
| -0.6% | -$24K | 2.98% | 10 |
|
|
2023
Q3 | $3.84M | Sell |
39,645
-200
| -0.5% | -$21K | 2.9% | 9 |
|
|
2023
Q2 | $4.34M | Sell |
39,845
-900
| -2% | -$95.9K | 3.06% | 8 |
|
|
2023
Q1 | $4.13M | Sell |
40,745
-4,793
| -11% | -$506K | 2.96% | 10 |
|
|
2022
Q4 | $5M | Buy |
45,538
+300
| +0.7% | +$31.1K | 3.65% | 5 |
|
|
2022
Q3 | $4.38M | Sell |
45,238
-300
| -0.7% | -$32K | 3.54% | 5 |
|
|
2022
Q2 | $4.95M | Sell |
45,538
-169
| -0.4% | -$19.2K | 3.57% | 4 |
|
|
2022
Q1 | $5.41M | Sell |
45,707
-340
| -0.7% | -$42.1K | 3.32% | 3 |
|
|
2021
Q4 | $6.48M | Sell |
46,047
-375
| -0.8% | -$48K | 3.8% | 2 |
|
|
2021
Q3 | $5.48M | Sell |
46,422
-200
| -0.4% | -$24.6K | 3.59% | 2 |
|
|
2021
Q2 | $5.41M | Buy |
46,622
+300
| +0.6% | +$35K | 3.45% | 2 |
|
|
2021
Q1 | $5.55M | Buy |
46,322
+65
| +0.1% | +$7.7K | 3.76% | 2 |
|
|
2020
Q4 | $5.07M | Sell |
46,257
-540
| -1% | -$58.7K | 3.92% | 2 |
|
|
2020
Q3 | $5.09M | Sell |
46,797
-825
| -2% | -$83.7K | 4.39% | 2 |
|
|
2020
Q2 | $4.35M | Sell |
47,622
-6,625
| -12% | -$599K | 4.08% | 2 |
|
|
2020
Q1 | $4.28M | Sell |
54,247
-1,598
| -3% | -$133K | 4.55% | 2 |
|
|
2019
Q4 | $4.85M | Sell |
55,845
-475
| -0.8% | -$39.8K | 3.85% | 2 |
|
|
2019
Q3 | $4.71M | Sell |
56,320
-1,302
| -2% | -$111K | 3.98% | 2 |
|
|
2019
Q2 | $4.85M | Sell |
57,622
-6,250
| -10% | -$492K | 4.16% | 1 |
|
|
2019
Q1 | $5.11M | Sell |
63,872
-9,240
| -13% | -$687K | 4.66% | 1 |
|
|
2018
Q4 | $5.29M | Buy |
+73,112
| New | +$5.14M | 5.32% | 1 |
|
Other funds holding ABT
Brooks Moore & Associates's ABT Position: Q2 2026 in Review
Brooks Moore & Associates increased its Abbott (ABT) stake by 18% in Q2 2026, buying an estimated $653K and bringing the position to 47,455 shares worth $4.31M. The position accounts for 1.93% of the portfolio, ranked #15.
Brooks Moore & Associates first reported a position in ABT in Q4 2018 and has held it in 31 quarters since. The position peaked at $6.48M in Q4 2021. 2,972 funds tracked by Wall St. Rank hold ABT as of Q2 2026.
- Brooks Moore & Associates held 47,455 shares of Abbott worth $4.31M as of Q2 2026.
- Brooks Moore & Associates bought 7,150 Abbott shares in Q2 2026, an estimated $653K.
- Abbott made up 1.93% of Brooks Moore & Associates's portfolio in Q2 2026, its #15 holding.
- Brooks Moore & Associates first reported a position in Abbott in Q4 2018 and has held it in 31 quarters since.
- Brooks Moore & Associates's Abbott position peaked at $6.48M in Q4 2021.
- 2,972 funds tracked by Wall St. Rank held Abbott as of Q2 2026.
Based on Brooks Moore & Associates's 13F filing for Q2 2026, filed 17 Aug 2026.